Peer review reports
From: Cystatin SN promotes epithelial-mesenchymal transition and serves as a prognostic biomarker in lung adenocarcinoma
Original Submission |
23 Mar 2022 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
12 Apr 2022 |
Reviewed |
Reviewer Report
|
13 Apr 2022 |
Reviewed |
Reviewer Report
|
29 Apr 2022 |
Author responded |
Author comments - Jun Zhao
|
Resubmission - Version 4 |
29 Apr 2022 |
Submitted |
Manuscript version 4
|
10 May 2022 |
Author responded |
Author comments - Jun Zhao
|
Resubmission - Version 5 |
10 May 2022 |
Submitted |
Manuscript version 5
|
12 May 2022 |
Author responded |
Author comments - Jun Zhao
|
Resubmission - Version 6 |
12 May 2022 |
Submitted |
Manuscript version 6
|
Publishing |
17 May 2022 |
Editorially accepted |
|
30 May 2022 |
Article published |
10.1186/s12885-022-09685-z
|
Learn about peer review